TSS, Inc. insider files to sell vested 11,100 shares ahead of September date
Rhea-AI Filing Summary
TSS, Inc. insider filing reports proposed and recent sales of common stock by an insider. The filing shows a proposed sale of 11,100 shares acquired on 06/27/2025 through restricted stock vesting for services, with an aggregate market value of $179,477.01 based on the filing. The issuer has 25,364,244 shares outstanding and the proposed sale lists NASDAQ as the exchange and an approximate sale date of 09/10/2025.
The notice also discloses prior sales by the same person within the past three months: 23,908 shares sold on 08/28/2025 for $386,343.72 and 2,917 shares sold on 08/27/2025 for $47,338.24. The filer certifies no undisclosed material adverse information and that the shares to be sold were obtained via a registered plan vesting.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans to sell vested restricted stock totaling 11,100 shares after recent sales; impact appears modest given share count.
The filing documents a proposed sale of 11,100 shares acquired through restricted stock vesting on 06/27/2025, with an aggregate market value of $179,477.01 and an approximate sale date of 09/10/2025 on NASDAQ. Recent sales by the same individual totaled 26,825 shares generating roughly $433,681.96 in proceeds across two trades on 08/27-08/28/2025. Relative to the issuer's 25.36 million shares outstanding, these transactions represent a small fractional dilution and are routine for insiders selling vested compensation. From a trading-impact perspective, the sizes are unlikely to move the market materially, though repeated insider selling may attract investor attention.
TL;DR: Transaction is typical post-vesting insider sale; disclosure is complete but may prompt governance questions about compensation timing.
The securities were acquired via restricted stock vesting under a registered plan and are being sold through a broker (Morgan Stanley Smith Barney). The filer affirms absence of undisclosed material adverse information. Proper Form 144 disclosure of recent sales and the proposed sale meets regulatory requirements. Governance observers may note the proximity of multiple insider sales in late August and a planned September sale, which could lead to routine shareholder inquiries about executive liquidity and compensation practices, though the absolute amounts are not large relative to total shares outstanding.